$0.03
Marizyme is a biotechnology business based in the US. Marizyme shares (MRZM) are listed on the OTCQB and all prices are listed in US Dollars.
Our top picks for where to buy Marizyme stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- No-cost financial planning and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Marizyme stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MRZM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Marizyme stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Marizyme stock price (OTCQB: MRZM)
Use our graph to track the performance of MRZM stocks over time.Marizyme shares at a glance
Latest market close | $0.03 |
---|---|
52-week range | $0.04 - $0.41 |
50-day moving average | $0.07 |
200-day moving average | $0.11 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.43 |
Is it a good time to buy Marizyme stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Marizyme price performance over time
Historical closes compared with the close of $0.0314 from 2024-07-25
1 week (2024-07-19) | -37.20% |
---|---|
1 month (2024-06-27) | -37.20% |
3 months (2024-04-26) | -68.60% |
6 months (2024-01-26) | -68.60% |
1 year (2023-07-27) | -68.60% |
---|---|
2 years (2022-07-26) | -98.94% |
3 years (2021-07-26) | 1.4 |
5 years (2019-07-23) | N/A |
Marizyme financials
Revenue TTM | $549,691 |
---|---|
Gross profit TTM | $129,925 |
Return on assets TTM | -39.86% |
Return on equity TTM | -3137.71% |
Profit margin | 0% |
Book value | $-0.08 |
Market Capitalization | $6.6 million |
TTM: trailing 12 months
Marizyme share dividends
We're not expecting Marizyme to pay a dividend over the next 12 months.
You may also wish to consider:
- Switch (SWCH.US) (0.61% forward annual dividend yield)
- KBR (KBR.US) (0.89% forward annual dividend yield)
Have Marizyme's shares ever split?
Marizyme's shares were split on a 1:29 basis on 26 July 2018. So if you had owned 29 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Marizyme shares – just the quantity. However, indirectly, the new 2800% higher share price could have impacted the market appetite for Marizyme shares which in turn could have impacted Marizyme's share price.
Marizyme share price volatility
Over the last 12 months, Marizyme's shares have ranged in value from as little as $0.04 up to $0.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Marizyme's is 0.343. This would suggest that Marizyme's shares are less volatile than average (for this exchange).
To put Marizyme's beta into context you can compare it against those of similar companies.
- Switch (SWCH.US): 0.5923
- Box (BOX.US): 0.863
- KBR (KBR.US): 0.909
Marizyme overview
Marizyme, Inc. , a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health. It's product portfolio includes DuraGraft, a first-in-class, De Novo granted and CE marked intra-operative vascular graft storage and flushing solution used during coronary artery bypass graft (CABG) surgeries; MATLOC, a point-of-care, lab-on-chip technology platform, developed for quantitative chronic kidney disease assessment; and Krillase, a protein enzyme that acts to break protein bonds and has applications in wound debridement, wound healing, dental care and thrombosi. The company also engages in the development of MAR-FG-001, a fat grafting technology for the use during fat grafting procedures. Marizyme, Inc. was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018.
Frequently asked questions
What percentage of Marizyme is owned by insiders?Currently 34.956% of Marizyme shares are held by insiders. When does the fiscal year end for Marizyme?
Marizyme's fiscal year ends in December. Where is Marizyme based?
Marizyme's address is: 555 Heritage Drive, Jupiter, FL, United States, 33458 What is Marizyme's ISIN number?
Marizyme's international securities identification number is: US5703721028
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question